The global rise in infectious diseases, including COVID-19 and influenza, has heightened the demand for accurate diagnostic tools, driving market growth. According to the National Center for Biotechnology Information, in January 2023, infectious diseases continue to be a major health concern globally, responsible for over 52 million mortalities annually, which represents 33.0% of total mortalities globally. Half of the global population remains vulnerable to new and recurring infectious diseases, with recent data showing approximately 14 million mortalities among children under 5 years old, 70.0% of which are due to vaccine-preventable diseases, predominantly in developing countries. Despite global efforts and advancements in awareness programs, significant challenges persist in the prevention and control of infectious diseases, particularly in Pakistan, where the burden of these diseases has seen minimal change over the years.

Get Sample Copy of this Report at

https://www.omrglobal.com/request-sample/polymerase-chain-reaction-pcr-technologies-market

Growing Demand for Personalized Medicine

The development of personalized medicine, which entails customizing medicines based on individual genetic profiles to improve patient outcomes, is being driven by PCR's ability to examine genetic information. For instance, in November 2023, Roche launched the LightCycler PRO System, a next-generation qPCR technology designed to advance clinical needs in molecular diagnostics and address public health challenges. The system combines gold-standard technology for quality, precision, and reliability, enabling accurate patient diagnosis and effective clinical decisions. It complements Roche's molecular PCR testing portfolio, enabling users to develop their tests and enabling over 200 LightMix Modular research assays and over 60 LightMix CE-IVD assays from TIB Molbiol.

Market Segmentation

Based on the application, the market is segmented into research applications, clinical diagnostics applications, forensic applications, and others (biotechnology, and environmental testing).
Based on the product, the market is segmented into instruments, standard PCR systems, real-time PCR systems, digital PCR systems, reagents and consumables, and software.
Based on the end-user, the market is segmented into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, and academic and research organizations.
Clinical Diagnostics Application is Projected to Hold the Largest Segment

The primary factors supporting the growth include the market growth of advanced diagnostics is driven by increased awareness among healthcare providers and patients on the benefits of a rapid and accurate diagnosis. For instance, in July 2024, Danaher launched two new centers of innovation in diagnostics, DH Diagnostics LLC Centers, to accelerate drug development and commercialization of companion diagnostics. The Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) Labs consolidate technology and tests across numerous Danaher divisions under one roof to minimize handoffs and advance the commercialization of patient-specific treatment.

Reagents and Consumables Segment to Hold a Considerable Market Share

The growth of healthcare facilities and laboratories, especially in emerging markets, is accelerating the adoption of PCR technologies for diagnostic purposes. For instance, in March 2021, PCR Biosystems introduced IsoFast Bst Polymerase reagents for rapid, robust, and sensitive DNA and RNA amplification. These reagents eliminate the need for high-temperature denaturation steps, allowing faster results without specialized equipment. It can be used for whole genome amplification, multiple displacement amplification, and isothermal amplification, with consistent results and sensitivities.

by Application (Dermatology, Ophthalmology, Dentistry, Oncology, Wound Healing, and Others),

by Product (Instruments, Reagents and Consumables, and Software) and

by End-User (Pharmaceutical and Biotechnology Industries, Clinical Diagnostics Labs and Hospitals, and Academic and Research Organizations)

Market Players Outlook

The major companies serving the global PCR market include Abbott Laboratories, Inc., Agilent Technologies, Inc., F.Hoffmann-La Roche AG, Siemens AG., and Thermo Fisher Scientific among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.

Recent Developments

In May 2023, Nuclein and Minute Molecular Diagnostics merged to develop a rapid, low-cost qPCR system. The combined company plans to enhance commercialization by expanding its molecular diagnostic test portfolio.


The Report Covers

Market value data analysis of 2023 and forecast to 2031.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the polymerase chain reaction (PCR) market. Based on the availability of data, information related to new products, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.


Inquire for Discount on this Report at

https://www.omrglobal.com/report-customization/polymerase-chain-reaction-pcr-technologies-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404